Emergent Biosolutions
EBS
EBS
255 hedge funds and large institutions have $1.72B invested in Emergent Biosolutions in 2022 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 78 increasing their positions, 95 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
255
Holders Change
+1
Holders Change %
+0.39%
% of All Funds
4.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
48
Increased
78
Reduced
95
Closed
43
Calls
$4.92M
Puts
$2.67M
Net Calls
+$2.26M
Net Calls Change
+$2.1M
Top Buyers
| 1 |
BlackRock
New York
|
$359M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$20.7M |
| 3 |
State Street
Boston,
Massachusetts
|
$142M |
| 4 |
Renaissance Technologies
New York
|
$14.7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
$56.2M |
